Literature DB >> 10755581

Adverse response to methylphenidate in combination with valproic acid.

L Gara1, W Roberts.   

Abstract

The use of methylphenidate (MPH) in combination with antiepileptic drugs is gaining acceptance for children with epilepsy who have the symptoms of attention-deficit hyperactivity disorder (ADHD). We report two cases of an adverse effect of dyskinesia and bruxism when MPH was given to children maintained on valproic acid. These adverse effects were rapid and severe. Because of the potential for serious and persistent side effects from this combination of medications, caution is warranted in the treatment of ADHD with MPH for children taking valproic acid. Further prospective studies of the use of valproic acid and MPH in combination are required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755581     DOI: 10.1089/cap.2000.10.39

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  2 in total

1.  Neurological adverse effects of methylphenidate may be misdiagnosed as meningoencephalitis.

Authors:  Luke Blagdon Snell; Dinkar Bakshi
Journal:  BMJ Case Rep       Date:  2015-06-16

Review 2.  Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

Authors:  J S Markowitz; K S Patrick
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.